Company: SCLXW
Filing Date: 2025-10-28
Form Type: PRE 14A
Source: 0001193125-25-253884
Chunk: 33

Company: Scilex Holding Co
Filing Date: 2025-10-28
Form: PRE 14A
Chunk 33
---
284 shares subject to options exercisable within 60 days of October 17, 2025, 9,147 shares                                                                                                                         
 held directly, an aggregate of 1,794 shares held through an entity owned by Dr. Ji, 161 shares held by Dr. Ji’s spouse and an aggregate of 8,350 shares held by family trusts for the benefit of Dr. Ji, his spouse and children. |

| (4) | Represents 15,271 shares subject to options exercisable within 60 days of October 17, 2025 and 652 shares 
 held directly.                                                                                            |

| (5) | Represents 7,558 shares subject to options exercisable within 60 days of October 17, 2025 and 3,214 shares 
 held directly.                                                                                             |

| (6) | Represents 9,980 shares subject to options exercisable within 60 days of October 17, 2025 and 65 shares 
 held directly.                                                                                          |

| (7) | Represents 19,103 shares subject to options exercisable within 60 days of October 17, 2025 and 714 shares 
 held directly.                                                                                            |

| (8) | Represents (a) 1,458,263 shares of Common Stock held directly and (b) 14,018 shares underlying the Private                                                                                                                                               
 Warrants (as defined in the Company’s Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2024 (the “2014 Form 10-K”))                                                                                                        
 held by SCLX JV, all of which are currently exercisable, in each case, transferred to SCLX JV in connection with the Equity Repurchase Transaction (as defined below). Does not include any shares of Series A Preferred Stock. SCLX JV holds 490,617    
 Private Warrants. In connection with the Reverse Stock Split, the SPAC Warrants (as defined in the 2024 Form 10-K and which include the Private Warrants) were adjusted in accordance with their terms such that                                         
 the number of SPAC Warrants outstanding was unchanged, but each SPAC Warrant now entitles the holder to purchase 1/35th of a share of Common Stock at an exercise price of $402.50 per whole share (provided that in no event shall the holder of any    
 such warrants be entitled, upon the exercise of such warrants, to receive a fractional interest in a share of Common Stock